Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Long-Term Debt Repayments (2020 - 2025)

LifeStance Health (LFST) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 99.37% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.2 million, a 97.5% decrease, with the full-year FY2025 number at $7.2 million, down 97.5% from a year prior.
  • Long-Term Debt Repayments was $1.8 million for Q4 2025 at LifeStance Health, roughly flat from $1.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $287.3 million in Q4 2024 to a low of $330000.0 in Q4 2021.
  • A 5-year average of $28.7 million and a median of $732000.0 in 2024 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: plummeted 99.68% in 2023, then skyrocketed 44168.1% in 2024.
  • LifeStance Health's Long-Term Debt Repayments stood at $330000.0 in 2021, then surged by 1880.61% to $6.5 million in 2022, then crashed by 90.07% to $649000.0 in 2023, then surged by 44168.1% to $287.3 million in 2024, then tumbled by 99.37% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Long-Term Debt Repayments are $1.8 million (Q4 2025), $1.8 million (Q3 2025), and $1.8 million (Q2 2025).